The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study

Cardiovasc Drugs Ther. 2001 Jan;15(1):79-87. doi: 10.1023/a:1011119003788.
No abstract available

MeSH terms

  • Aldosterone / blood
  • Double-Blind Method
  • Eplerenone
  • Heart Failure / drug therapy*
  • Heart Failure / etiology
  • Heart Failure / pathology
  • Humans
  • Mineralocorticoid Receptor Antagonists / administration & dosage
  • Mineralocorticoid Receptor Antagonists / adverse effects
  • Mineralocorticoid Receptor Antagonists / therapeutic use*
  • Multicenter Studies as Topic
  • Myocardial Infarction / complications*
  • Randomized Controlled Trials as Topic
  • Research Design
  • Sample Size
  • Spironolactone / administration & dosage
  • Spironolactone / adverse effects
  • Spironolactone / analogs & derivatives*
  • Spironolactone / therapeutic use*
  • Survival Analysis
  • Systole

Substances

  • Mineralocorticoid Receptor Antagonists
  • Spironolactone
  • Aldosterone
  • Eplerenone